| Literature DB >> 35800630 |
Keiji Wada1, Ryo Tamaki1, Tomohisa Inoue1, Kenji Hagiwara1, Ken Okazaki1.
Abstract
Introduction: Spine surgery is challenging in hemodialysis (HD)-dependent patients owing to their poor general condition. However, postoperative complications and the mortality and survival rates have not been specifically evaluated in a wide series. This study aimed to elucidate postoperative complications and the survival rate in cervical spine surgery in HD patients.Entities:
Keywords: cervical spine; chronic glomerulonephritis; complication; destructive spondyloarthropathy; diabetes; hemodialysis; survival rate
Year: 2021 PMID: 35800630 PMCID: PMC9200424 DOI: 10.22603/ssrr.2021-0173
Source DB: PubMed Journal: Spine Surg Relat Res ISSN: 2432-261X
Patients’ Characteristics.
| DSA group
| Non-DSA group
| P | |
|---|---|---|---|
| Sex (male:female) | 64:36 | 11:10 | 0.333a |
| Age (yr) | 62.9±7.5 | 59.9±6.8 | 0.097b |
| Dialysis period (yr) | 21.7±8.2 | 26.5±8.4 | 0.018*b |
| Cause of dialysis | 0.383a | ||
| Chronic glomerulonephritis | 45 (45%) | 21 (57.1%) | |
| Diabetes | 11 (11%) | 3 (14.3%) | |
| Toxemia of pregnancy | 4 (4%) | 2 (9.5%) | |
| Nephrotic syndrome | 4 (4%) | 2 (9.5%) | |
| Polycystic kidney disease | 4 (4%) | 0 | |
| Nephrosclerosis | 3 (3%) | 0 | |
| Others | 8 (8%) | 1 (4.8%) | |
| Unknown | 21 (21%) | 1 (4.8%) |
Data expression: n, %
P-value: a, Fisher’s exact test; b, unpaired t-test, *, statistically significant
Surgical Results.
| DSA group
| Non-DSA group
| P | |
|---|---|---|---|
| Operative time (min) | 196.8±86.0 | 155.7±56.4 | 0.039*b |
| Blood loss (mL) | 443.6±469.1 | 792.9±871.9 | 0.011*b |
| mJOA score | |||
| Preoperative | 4.4±2.9 | 3.9±2.0 | 0.448b |
| Postoperative | 8.9±3.3 | 8.0±3.0 | 0.246b |
| Recovery | 4.5±2.9 | 4.1±2.8 | 0.557b |
mJOA, modified Japanese Orthopaedic Association
Data expression: n, %
P-value: b, unpaired t-test, *, statistically significant
Types of Surgery Performed.
| Surgery | DSA
| Non-DSA
| P |
|---|---|---|---|
| 0.436a | |||
| Laminoplasty | 49 (49%) | 19 (90.5%) | |
| Laminoplasty+ASF | 12 (12%) | 0 | |
| Laminoplasty+posterior fusion (LM) | 10 (10%) | 0 | |
| Laminoplasty+posterior fusion (PS) | 10 (10%) | 0 | |
| ASF | 9 (9%) | 1 (4.8%) | |
| Occipito-cervical fusion | 3 (3%) | 0 | |
| MB+laminoplasty | 3 (3%) | 0 | |
| Others | 4 (4%) | 1 (4.8%) |
ASF, anterior spinal fusion, LM, lateral mass screw, PS, pedicle screw, MB, Magerl and Brooks procedure
Data expression: n, %
P-value: a, Fisher’s exact test
Postoperative Complications.
| Complications | DSA
| Non-DSA
| P |
|---|---|---|---|
| Gastrointestinal dysfunction | 6 (6%) | 2 (9.5%) | 0.626 |
| Coronary artery disease | 2 (2%) | 1 (4.8%) | 0.439 |
| Pneumonia | 3 (3%) | 0 | >0.999 |
| Neurological deterioration | 2 (2%) | 1 (4.8%) | 0.439 |
| Hyperkalemia | 2 (2%) | 0 | >0.999 |
| Consciousness disorder | 2 (2%) | 0 | >0.999 |
| Others | 8 (8%) | 2 (9.5%) | 0.684 |
| Total | 23 (23%) | 4 (19%) | 0.782 |
| Inpatient mortality | 3 (3%) | 0 | >0.999 |
Data expression: n, %
P-value: Fisher’s exact test
Comparison of Surgical Results between Patients on Hemodialysis for More than 21 Years and Those on Hemodialysis for Less than 20 Years.
| HD<20years
| HD>21years
| P-value | |
|---|---|---|---|
| Sex (male:female) | 32:15 | 43:31 | 0.338a |
| Age (yr) | 65.8±7.6 | 60.2±6.5 | <0.001*b |
| Dialysis period (yr) | 13.8±4.8 | 28.1±4.5 | - |
| Operative time (min) | 185.2±90.6 | 191.9±77.9 | 0.672b |
| Blood loss (mL) | 382.8±384.3 | 587.4±660.6 | 0.063b |
| Complications | |||
| Gastrointestinal dysfunction | 5 (10.6%) | 3 (4.1%) | 0.259a |
| Coronary artery disease | 0 (0%) | 3 (4.1%) | 0.281a |
| Pneumonia | 0 (0%) | 3 (4.1%) | 0.281a |
| Neurological deterioration | 1 (2.1%) | 2 (2.7%) | >0.999a |
| Hyperkalemia | 2 (2%) | 0 | 0.149a |
| Consciousness disorder | 2 (2%) | 0 | 0.149a |
| Others | 3 (6.4%) | 7 (9.5%) | 0.739a |
| Total | 12 (25.5%) | 15 (20.3%) | 0.510a |
| Inpatient mortality | 1 (2.1%) | 2 (2.7%) | >0.999a |
Data expression: n, %
P-value: a, Fisher’s exact test; b, unpaired t-test, *, statistically significant
Figure 1.Kaplan–Meier analysis of postoperative survival rates of all HD patients (A), patients with diabetes (DM) vs. non-DM (B), and chronic glomerulonephritis (CGN) vs. DM (C).